14 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... American College of Cardiology ... HeartFailure #Management #CHF ... guideline #ACCAHA2017 #cardiology ... #treatment #algorithm
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... recommended by the ACC ... /ambcarerx #CHF ... #HFrEF #Pharmacology ... #StageC #Cardiology
Recommended Therapeutic Approach to the Patient with Hypertrophic Cardiomyopathy (HOCM)
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers;
Cardiomyopathy (HOCM) ACE ... receptor blockers; HF ... Cardiomyopathy #Algorithm ... #Management #Cardiology
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... Guidelines: • ACC ... iron #deficiency #CHF ... #cardiology #treatment
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Osteoporosis Treatment ... Algorithm Evaluate ... • Recommend pharmacologic ... #Algorithm #Management
Heart Failure Medications Summary
Inhibitors of the Renin-Angiotensin System:
 • ACE Inhibitors: Benazepril, Captopril, Enalapril, Lisinopril, Quinapril,
Renin-Angiotensin System: • ACE ... #Medications #CHF ... #cardiology #pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #decisionaid #cardiology ... #hematology #warfarin
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... diagnosis #management #cardiology ... #pharmacology # ... sCHF
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... patients with CKD, HF ... ACE inhibitors, ... #Hyperkalemia #Pharmacology
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Revascularization, treatment ... NSAlDs, ACE-inhibitors ... #Checklist #CHF ... #HeartFailure #Cardiology